Annual Drug Patent Expirations for CIPRODEX Ciprodex is a drug marketed by Novartis and is included in one NDA. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Novartis drug CIPRODEX appeared …
New patent expiration for Novartis drug CIPRODEX Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
This chart shows the drugs with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Lithu…
Which pharmaceutical drugs have the most drug patents in Lithuania? Read Post »
Annual Drug Patent Expirations for ORAVIG Oravig is a drug marketed by Galt Pharms and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Galt Pharms drug ORAVIG appeared first on Drug…
New patent expiration for Galt Pharms drug ORAVIG Read Post »
Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug ANORO…
New patent expiration for Glaxosmithkline drug ANORO ELLIPTA Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug T…
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug T…
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Bausch drug VANOS appeared first on DrugPa…
Get new actionable insights and updates from BiotechBlog
